Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |